3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Phase 2
1
Status
Terminated
1
Completed
1
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Interventional
2
Sponsor
Cancer Type
Thoracic
2
Conditions
Breast Neoplasms
67
Prostatic Neoplasms
49
Multiple Myeloma
29
Neoplasm Metastasis
27
Osteoporosis
16
Pain
15
Carcinoma, Non-Small-Cell Lung
10
Neoplasms
9
Lung Neoplasms
8
Osteosarcoma
7
Neoplasms, Plasma Cell
7
Neuroblastoma
6
Carcinoma, Renal Cell
6
Bone Diseases, Metabolic
6
Humoral Hypercalcemia Of Malignancy
5
Bone Neoplasms
5
Fractures, Bone
4
Bone Diseases
4
Sarcoma, Ewing
3
Sarcoma
3
Lymphoma
3
Kidney Neoplasms
3
Uterine Cervical Neoplasms
2
Triple Negative Breast Neoplasms
2
Spinal Cord Compression
2
Small Cell Lung Carcinoma
2
Rhabdomyosarcoma
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Pleural Effusion, Malignant
2
Ovarian Neoplasms
2
Interventions
Cisplatin
8
Carboplatin
8
Bevacizumab
8
Pleurodesis
7
Talc
6
Paclitaxel
6
Docetaxel
5
Povidone-Iodine
4
Doxycycline
4
Taxes
3
Gemcitabine
3
Drug Therapy
3
Chest Tubes
3
aldesleukin
2
Zoledronic Acid
2
Trastuzumab
2
Thoracoscopy
2
Sodium Chloride
2
Silver Nitrate
2
Pharmaceutical Preparations
2
Nivolumab
2
Interleukin-2
2
Fluorodeoxyglucose F18
2
Fentanyl
2
Erlotinib Hydrochloride
2
Cetuximab
2
Bortezomib
2
viscum album peptide
1
tocilizumab
1
tipifarnib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Interventional
×
Pleural Effusion, Malignant
×
Zoledronic Acid
×
Clear all
NCT01004510
2012-12-04
ZAP
Rochester General Hospital
Phase 2
Terminated
3 enrolled
5 charts
NCT00099541
2009-11-23
Non-small Cell Lung Cancer Registry
Novartis
Phase 4
Completed
300 enrolled